Concepts (104)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Inflammatory Bowel Diseases | 5 | 2019 | 39 | 0.960 |
Why?
|
| Granuloma | 1 | 2022 | 17 | 0.780 |
Why?
|
| Stomach | 1 | 2022 | 42 | 0.770 |
Why?
|
| Gastrointestinal Agents | 2 | 2017 | 14 | 0.590 |
Why?
|
| Insurance, Pharmaceutical Services | 1 | 2017 | 9 | 0.560 |
Why?
|
| Biological Therapy | 1 | 2017 | 5 | 0.560 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2017 | 244 | 0.500 |
Why?
|
| Gastroenterology | 2 | 2020 | 14 | 0.340 |
Why?
|
| Drug Industry | 2 | 2019 | 12 | 0.320 |
Why?
|
| Disclosure | 2 | 2019 | 19 | 0.320 |
Why?
|
| Conflict of Interest | 2 | 2019 | 15 | 0.320 |
Why?
|
| Colitis, Ulcerative | 2 | 2017 | 28 | 0.270 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2016 | 109 | 0.240 |
Why?
|
| Echocardiography, Transesophageal | 2 | 2014 | 43 | 0.210 |
Why?
|
| Health Knowledge, Attitudes, Practice | 2 | 2016 | 281 | 0.210 |
Why?
|
| Catheterization, Central Venous | 2 | 2014 | 36 | 0.200 |
Why?
|
| Financial Support | 2 | 2019 | 9 | 0.200 |
Why?
|
| Hospitalization | 3 | 2017 | 193 | 0.190 |
Why?
|
| Ontario | 2 | 2017 | 11 | 0.180 |
Why?
|
| Diagnosis, Differential | 1 | 2022 | 368 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 234 | 0.180 |
Why?
|
| Proportional Hazards Models | 2 | 2017 | 217 | 0.160 |
Why?
|
| Middle Aged | 8 | 2018 | 6901 | 0.160 |
Why?
|
| Humans | 13 | 2022 | 27125 | 0.160 |
Why?
|
| Lymphocytosis | 1 | 2018 | 2 | 0.160 |
Why?
|
| Authorship | 1 | 2018 | 13 | 0.160 |
Why?
|
| Esophagitis | 1 | 2018 | 7 | 0.160 |
Why?
|
| Colorectal Neoplasms | 1 | 2020 | 133 | 0.160 |
Why?
|
| Physicians | 1 | 2019 | 80 | 0.150 |
Why?
|
| Nutritional Support | 1 | 2017 | 2 | 0.150 |
Why?
|
| Malnutrition | 1 | 2017 | 30 | 0.140 |
Why?
|
| Adult | 7 | 2018 | 7494 | 0.140 |
Why?
|
| Fasting | 1 | 2017 | 80 | 0.140 |
Why?
|
| Nutritional Status | 1 | 2017 | 75 | 0.140 |
Why?
|
| Mesalamine | 1 | 2016 | 5 | 0.130 |
Why?
|
| Enterocolitis, Pseudomembranous | 1 | 2016 | 12 | 0.130 |
Why?
|
| Crohn Disease | 1 | 2016 | 26 | 0.130 |
Why?
|
| Retrospective Studies | 3 | 2017 | 2461 | 0.130 |
Why?
|
| Glucocorticoids | 1 | 2016 | 114 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2017 | 119 | 0.130 |
Why?
|
| Medication Adherence | 1 | 2016 | 46 | 0.120 |
Why?
|
| Vaccines | 1 | 2015 | 29 | 0.120 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 108 | 0.120 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2015 | 88 | 0.110 |
Why?
|
| Female | 8 | 2018 | 14625 | 0.110 |
Why?
|
| Male | 7 | 2018 | 13008 | 0.110 |
Why?
|
| Vaccination | 1 | 2015 | 171 | 0.110 |
Why?
|
| Young Adult | 5 | 2018 | 2628 | 0.100 |
Why?
|
| Anemia, Macrocytic | 1 | 2012 | 2 | 0.100 |
Why?
|
| Dideoxynucleosides | 1 | 2012 | 12 | 0.100 |
Why?
|
| Anti-HIV Agents | 1 | 2012 | 17 | 0.100 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2014 | 171 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2016 | 497 | 0.100 |
Why?
|
| Lactic Acid | 1 | 2012 | 89 | 0.090 |
Why?
|
| Echocardiography | 1 | 2011 | 108 | 0.090 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2283 | 0.090 |
Why?
|
| HIV Infections | 1 | 2012 | 149 | 0.080 |
Why?
|
| Cross-Sectional Studies | 2 | 2019 | 932 | 0.060 |
Why?
|
| Prospective Studies | 2 | 2020 | 1223 | 0.060 |
Why?
|
| Jugular Veins | 2 | 2014 | 12 | 0.050 |
Why?
|
| Aged | 3 | 2018 | 5217 | 0.050 |
Why?
|
| Learning Curve | 1 | 2020 | 13 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 2990 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2020 | 216 | 0.040 |
Why?
|
| Esophagoscopy | 1 | 2018 | 15 | 0.040 |
Why?
|
| Deglutition Disorders | 1 | 2018 | 23 | 0.040 |
Why?
|
| Lymphocytes | 1 | 2018 | 83 | 0.040 |
Why?
|
| Gastroesophageal Reflux | 1 | 2018 | 84 | 0.040 |
Why?
|
| Diet Records | 1 | 2017 | 10 | 0.040 |
Why?
|
| Dairy Products | 1 | 2017 | 5 | 0.040 |
Why?
|
| Tertiary Care Centers | 1 | 2017 | 26 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2017 | 90 | 0.030 |
Why?
|
| Colectomy | 1 | 2016 | 4 | 0.030 |
Why?
|
| Infliximab | 1 | 2016 | 6 | 0.030 |
Why?
|
| Quality Improvement | 1 | 2017 | 113 | 0.030 |
Why?
|
| Adalimumab | 1 | 2016 | 3 | 0.030 |
Why?
|
| Diet | 1 | 2017 | 224 | 0.030 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 298 | 0.030 |
Why?
|
| Clostridium Infections | 1 | 2016 | 66 | 0.030 |
Why?
|
| Hepatitis A Vaccines | 1 | 2015 | 1 | 0.030 |
Why?
|
| Chickenpox Vaccine | 1 | 2015 | 3 | 0.030 |
Why?
|
| Perception | 1 | 2016 | 84 | 0.030 |
Why?
|
| Self Report | 1 | 2016 | 116 | 0.030 |
Why?
|
| Hepatitis B Vaccines | 1 | 2015 | 3 | 0.030 |
Why?
|
| Meningococcal Vaccines | 1 | 2015 | 5 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 316 | 0.030 |
Why?
|
| Herpes Zoster Vaccine | 1 | 2015 | 10 | 0.030 |
Why?
|
| Pneumococcal Vaccines | 1 | 2015 | 20 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2018 | 1098 | 0.030 |
Why?
|
| Influenza Vaccines | 1 | 2015 | 48 | 0.030 |
Why?
|
| Papillomavirus Vaccines | 1 | 2015 | 50 | 0.030 |
Why?
|
| Anesthesia, General | 1 | 2014 | 30 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2014 | 191 | 0.030 |
Why?
|
| Heart Atria | 1 | 2014 | 171 | 0.030 |
Why?
|
| Erythrocyte Indices | 1 | 2012 | 6 | 0.020 |
Why?
|
| Child | 1 | 2018 | 2164 | 0.020 |
Why?
|
| Cell Size | 1 | 2012 | 22 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2014 | 387 | 0.020 |
Why?
|
| Carotid Artery Injuries | 1 | 2011 | 12 | 0.020 |
Why?
|
| Pregnancy | 1 | 2016 | 1148 | 0.020 |
Why?
|
| Point-of-Care Systems | 1 | 2011 | 20 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2015 | 927 | 0.020 |
Why?
|
| Risk Factors | 1 | 2016 | 2036 | 0.020 |
Why?
|
| Biomarkers | 1 | 2012 | 736 | 0.020 |
Why?
|